Ingrid Baasland

Ingrid Baasland is a Researcher at the Department of Public Health and Nursing, Norwegian University of Science and Technology (NTNU), and a Consultant at the Department of Obstetrics and Gynecology, St. Olavs Hospital since 2003. Her work focuses on cervical dysplasia and cervical cancer prevention within the Norwegian Cervical Cancer Screening Program. She holds a Cand.med. degree from the University of Oslo (1995).

Her educational background:

• Cand.med., University of Oslo, 1995

Dr. Baasland's research centers on cervical cancer prevention, specifically avoiding overtreatment of cervical dysplasia through biomarker prediction of regression or progression. Her expertise spans cervical intraepithelial neoplasia, colposcopy, HPV vaccination, health literacy, e-health literacy, and cervical cancer screening implementation. She actively contributes to national guideline development for gynecological cancer prevention and has led the CINDERELLA study investigating individualized dysplasia treatment.

Her publication record (2019-2025) demonstrates consistent focus on cervical dysplasia management and screening program optimization. Key contributions include longitudinal analysis of CIN1 outcomes, HPV self-sampling for non-attenders, screening's impact on cervical cancer mortality, and healthcare provider/patient experiences with program changes. Her work bridges clinical research, public health policy, and practical implementation in Norway's national screening framework.

Dr. Baasland maintains active public engagement through media interviews (NRK, Adresseavisen), professional lectures, and guideline development for the Norwegian Directorate of Health. She regularly contributes to national informational materials on cervical dysplasia management and participates in clinical training programs for colposcopy and screening interpretation.